Premium
Our 2014 approach to breakthrough invasive fungal infections
Author(s) -
Maschmeyer Georg,
Patterson Thomas F.
Publication year - 2014
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/myc.12213
Subject(s) - antifungal , intensive care medicine , epidemiology , medicine , antifungal drugs , candida infections , invasive candidiasis , fluconazole , dermatology
Summary Evidence‐based clinical pathways to direct antifungal treatment options in patients with breakthrough fungal infections during current systemic antifungal therapy are not available. Nonetheless, for defined settings of such breakthrough infections approaches to management can be recommended based on clinical, epidemiological, pharmacological and in vitro susceptibility data.